[Involvement of dopamine receptor in the pathogenesis of hypertension and hypertensive target-organ damage].
Sanada
Hironobu
H
Department of Internal Medicine III, Fukushima Medical University School of Medicine.
Yatabe
Junichi
J
Sasaki
Midori
M
Watanabe
Tsuyoshi
T
D000818:Animals; D004298:Dopamine / Q000502:physiology; D018491:Dopamine Agonists / Q000627:therapeutic use; D018818:Fenoldopam / Q000627:therapeutic use; D054771:G-Protein-Coupled Receptor Kinase 4; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D009318:Natriuresis; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D011954:Receptors, Dopamine / Q000145:classification / Q000502:physiology*; D015398:Signal Transduction; D012964:Sodium / Q000378:metabolism
D018491:Dopamine Agonists; D011954:Receptors, Dopamine; D012964:Sodium; D017346:Protein Serine-Threonine Kinases; D054771:G-Protein-Coupled Receptor Kinase 4; C517855:GRK4 protein, human; D018818:Fenoldopam; D004298:Dopamine